Prostate surgery trial keeping the urethra intact
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a robot-assisted prostate surgery method that aims to preserve the entire urethra (the tube that carries urine out of the body) to help maintain continence. It's for men with low- to intermediate-risk prostate cancer who haven't had prior prostate treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are expected to live at least 10 more years based on your overall health.
- You have not had any prior treatment for prostate problems, like laser surgery, TURP, or focal therapy.
- You have never had radiation to your pelvis or prostate, or had major surgery in your belly or rectum.
- You have not had a stroke or a brain event that caused lasting symptoms, and you don't have a neurological disease like Parkinson's.
- Your PSA level is 15 or lower, your prostate is 80 mL or smaller, and your biopsy shows a low or intermediate cancer grade (ISUP 1, 2, or 3).
- Your biopsy had at least 12 samples taken from both sides of the prostate, and you have had an MRI if your cancer grade is 3+4 or higher.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a new robotic surgical technique (with a special urethra repair) to standard robotic surgery and laparoscopic surgery for men with newly diagnosed prostate cancer that has not spread. The goal is to see which approach best preserves urinary control.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
This trial tests whether using a combined PSMA-PET/MRI and ultrasound navigation system during robot-assisted prostate removal can help the surgeon remove the cancer more completely while preserving surrounding tissue. It is for patients with early-stage prostate cancer that is just starting to spread outside the prostate.
This trial tests a robot-assisted method for taking prostate biopsies using a new type of ultrasound probe. It may help men with certain high-risk features get a more precise diagnosis.
This trial tests whether adding a 3D augmented-reality model to standard robot-assisted prostate surgery can help doctors remove the cancer while better preserving sexual function. It is for men whose MRI shows the cancer may have slightly spread outside the prostate.
This trial compares two nerve-sparing surgery techniques for prostate cancer to see which one better protects urinary control and sexual function while still removing the cancer. It may help men with early-stage prostate cancer who are planning to have robotic surgery.
Hear when a new Prostate Cancer (Localized), Urinary Incontinence (C61) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.